Related Experiment Videos
Real-World Safety of Concurrent Measles-Mumps-Rubella and Varicella Vaccination in Korean Infants: A Multicenter
Sujin Choi1, Bin Ahn2,3, Yeonjoo Lee4
1Department of Pediatrics, Konkuk University Medical Center, Seoul 05030, Republic of Korea.
Insights
Concurrent measles, mumps, rubella (MMR) and varicella vaccination in Korean infants showed a transient increase in fever 7-13 days post-vaccination. This real-world safety data supports the continued use of separate MMR + V injections.
Area of Science:
- Pediatrics
- Immunology
- Public Health
Background:
- Co-administration of Measles, Mumps, Rubella (MMR) and varicella vaccines is common for optimal coverage.
- Safety concerns, particularly febrile convulsions, persist with combined vaccination strategies.
- South Korea utilizes a separate-injection approach for MMR and varicella vaccines (MMR + V) during a single visit.
Purpose of the Study:
- To evaluate the real-world safety of concurrent MMR + V vaccination in Korean infants.
- To assess adverse events, specifically fever and febrile convulsions, following MMR + V administration.
- To analyze the safety profile of domestically implemented MAV/06 and Oka-derived varicella vaccine strains.
Main Methods:
- A multicenter self-controlled case series (SCCS) study was conducted.
- Included children aged 12-23 months who received MMR + V and hepatitis A vaccine (HAV) between 2015 and 2024.
- Electronic health records were used to identify adverse events, with adjusted relative risks estimated via conditional Poisson regression.
Main Results:
- A peak in adverse events, primarily fever (aRR, 4.27), occurred 7-13 days post-MMR + V.
- Increased risks of sick visits (aRR, 2.15) and acute care visits (aRR, 2.13) were confined to this period.
- Febrile convulsions were uncommon (aRR, 5.37), with no excess risks during HAV or overlap periods.
Conclusions:
- Concurrent MMR + V vaccination in Korean infants, predominantly using the MAV/06 strain, resulted in expected, transient fever increases.
- No serious or sustained safety signals were identified.
- The findings support the continued use of Korea's separate-injection MMR + V strategy.
Background:
Measles, mumps, rubella (MMR) and varicella vaccines are often co-administered to optimize coverage, yet safety concerns regarding febrile convulsions persist. In South Korea, MMR and varicella vaccines are administered as separate injections during a single visit (MMR + V). This study evaluated the real-world safety of concurrent MMR + V vaccination, focusing on the domestically implemented MAV/06 and Oka-derived strains.
Methods:
We conducted a multicenter self-controlled case series (SCCS) study of children aged 12-23 months who received MMR + V and hepatitis A vaccine (HAV) between 2015 and 2024. Using electronic health records, we identified predefined adverse events (AEs), including fever and healthcare visits. Adjusted relative risks (aRRs) were estimated using conditional Poisson regression.
Results:
Among 3035 children (52.3% male; median age, 12 months), 71.7% received the MAV/06 varicella strain. A distinct peak in AEs occurred 7-13 days after MMR + V administration, with fever showing the greatest increase (aRR, 4.27; 95% CI, 2.76-6.60). The risks of total sick visits (aRR, 2.15; 95% CI, 1.70-2.71) and acute care visits (aRR, 2.13; 95% CI, 1.46-3.10) were similarly confined to this interval and returned to baseline thereafter. Febrile convulsions were uncommon (aRR, 5.37; 95% CI, 1.20-24.01). No excess risks were observed during the HAV or overlap periods, and no synergistic effects of intensive multi-vaccine administration were detected.
Conclusions:
Concurrent administration of MMR and varicella vaccines in Korean infants-predominantly using the MAV/06 strain-was associated only with expected, transient increases in fever during days 7-13 postvaccination. No serious or sustained safety signals were identified, supporting the continued use of Korea's separate-injection MMR + V strategy.
Related Concept Videos
Vaccinations
Respiratory Syncytial Virus Disease
Chickenpox
Vaccines
Cytomegalovirus Disease
Viral Meningitis